
Julia Rotow
Clinical Director, Lowe Center for Thoracic Oncology · Mass General Brigham
Credentials: · · · · ·
History
- Present
Lowe Center for Thoracic Oncology · Mass General Brigham
- Present
Clinical Research · Mass General Brigham
- Present
2008–2012
Research
Understanding and targeting resistance mechanisms in NSCLC
Review · Nature reviews. Cancer · 2017 · First of 2 authors · 774 citations
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing
Cell · 2020 · 568 citations
Nature Genetics · 2017 · 464 citations

14 papers

12 papers

12 papers

10 papers · 10 as a resident

9 papers
- MA
9 papers
- CM
8 papers

8 papers
Clinical trials
- 2020–2026
Plasma-Adapted First-Line Pembro In NSCLC
Principal investigator · Active not recruiting · Phase 2
Julia K. Rotow, MD
- 2014–2026
Principal investigator · Active not recruiting
Dana-Farber Cancer Institute
- 2026–2029
Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
Site PI · Recruiting · Phase 2
Massachusetts General Hospital


